Exegenesis Bio
Pre-clinicalExegenesis Bio develops gene therapies for rare genetic diseases using novel delivery technologies.
Founded
2019
Focus
RNA & Gene Therapy
About
Exegenesis Bio develops gene therapies for rare genetic diseases using novel delivery technologies.
Funding History
2Total raised: $105M
Series B$65MCBC GroupDec 15, 2021
Series A$40MQiming Venture PartnersAug 15, 2020
Company Info
TypePrivate
Founded2019
LocationPhiladelphia, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile